MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-22-2025
Intuitive Surgical Retained Earnings 2011-2026 | ISRG
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Intuitive Surgical
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.8 B | 4.74 B | 3.5 B | 4.76 B | 3.26 B | 2.49 B | 1.52 B | 61.4 M | 1.57 B | 899 M | 488 M | 979 M | 1.33 B | 902 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.8 B | 61.4 M | 2.38 B |
Quarterly Retained Earnings Intuitive Surgical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.42 B | 7.61 B | 7.14 B | 6.8 B | 6.13 B | 5.58 B | 5.07 B | 4.74 B | 4.21 B | - | 3.4 B | 3.5 B | 4.02 B | - | 4.86 B | 4.76 B | 4.39 B | 4.02 B | 3.51 B | 3.26 B | 3.26 B | 3.26 B | 3.26 B | 2.49 B | 2.49 B | 2.49 B | 2.49 B | 1.52 B | 1.52 B | 1.52 B | 1.52 B | 115 M | 115 M | 115 M | 115 M | 1.57 B | 1.57 B | 1.57 B | 1.57 B | 899 M | 899 M | 899 M | 899 M | 488 M | 488 M | 488 M | 488 M | 979 M | 979 M | 979 M | 979 M | 1.33 B | 1.33 B | 1.33 B | 1.33 B | 902 M | 902 M | 902 M | 902 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 7.61 B | 115 M | 2.46 B |
Retained Earnings of other stocks in the Medical instruments industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
14.9 B | $ 19.11 | -1.04 % | $ 9.75 B |  USA |
 |
Becton, Dickinson and Company
BDX
|
16.6 B | $ 194.62 | -0.57 % | $ 56 B | USA |
 |
Luminex Corporation
LMNX
|
83.8 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
-120 M | - | -9.52 % | $ 20.6 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
-250 M | $ 8.8 | -16.82 % | $ 177 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
-223 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
548 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
-11.9 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
2.13 B | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.13 B | - | -0.02 % | $ 16.3 B | USA |
 |
Alcon
ALC
|
19.4 B | $ 78.92 | -0.49 % | $ 40.4 B |  Schweiz |
 |
Harvard Bioscience
HBIO
|
-146 M | $ 0.67 | 1.38 % | $ 28.4 M | USA |
 |
AtriCure
ATRC
|
-402 M | $ 39.59 | -1.47 % | $ 1.86 B | USA |
 |
Atrion Corporation
ATRI
|
382 K | - | - | $ 810 M | USA |
 |
ICU Medical
ICUI
|
690 M | $ 142.71 | -1.33 % | $ 3.48 B | USA |
 |
electroCore
ECOR
|
-165 M | $ 4.51 | -3.12 % | $ 24.9 K | USA |
 |
iRhythm Technologies
IRTC
|
-759 M | $ 177.87 | -0.39 % | $ 5.55 B | USA |
 |
AngioDynamics
ANGO
|
-429 M | $ 12.82 | -1.38 % | $ 524 M | USA |
 |
Isoray
ISR
|
-232 M | - | 0.03 % | $ 108 M | USA |
 |
The Cooper Companies
COO
|
7.64 B | $ 82.0 | -0.57 % | $ 16.3 B | USA |
 |
Repro Med Systems
KRMD
|
-23.3 M | $ 5.82 | 2.28 % | $ 265 M | USA |
 |
Glaukos Corporation
GKOS
|
-599 M | $ 112.87 | -1.1 % | $ 5.47 B | USA |
 |
LeMaitre Vascular
LMAT
|
145 M | $ 81.43 | -1.9 % | $ 1.83 B | USA |
 |
Haemonetics Corporation
HAE
|
352 M | $ 80.27 | -1.06 % | $ 4.04 B | USA |
 |
InfuSystem Holdings
INFU
|
-59.3 M | $ 8.86 | -0.56 % | $ 183 M | USA |
 |
Masimo Corporation
MASI
|
1.49 B | $ 130.07 | -0.76 % | $ 6.93 B | USA |
 |
Merit Medical Systems
MMSI
|
696 M | $ 88.04 | -0.59 % | $ 5.13 B | USA |
 |
Microbot Medical
MBOT
|
-79.5 M | $ 1.97 | -4.15 % | $ 20.1 M |  Israel |
 |
Milestone Scientific
MLSS
|
-128 M | $ 0.27 | -0.22 % | $ 21.5 M | USA |
 |
Nephros
NEPH
|
-144 M | $ 4.91 | 4.13 % | $ 51 M | USA |
 |
OraSure Technologies
OSUR
|
-103 M | $ 2.39 | -3.24 % | $ 178 M | USA |
 |
NeuroMetrix
NURO
|
-218 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
-487 M | $ 21.77 | -0.68 % | $ 3.75 B | USA |
 |
Pro-Dex
PDEX
|
35.9 M | $ 38.38 | -0.56 % | $ 126 M | USA |
 |
Predictive Oncology
POAI
|
-180 M | - | - | $ 32.4 M | USA |
 |
Pulse Biosciences
PLSE
|
-337 M | $ 13.66 | -0.29 % | $ 656 M | USA |
 |
ResMed
RMD
|
3.61 B | $ 241.11 | -0.82 % | $ 35.2 B | USA |
 |
Repligen Corporation
RGEN
|
433 M | $ 163.8 | -1.67 % | $ 9.13 M | USA |
 |
BioLife Solutions
BLFS
|
-335 M | $ 24.25 | -1.66 % | $ 1.12 B | USA |
 |
STERIS plc
STE
|
2.48 B | $ 254.18 | -0.5 % | $ 25.1 B | USA |
 |
Stereotaxis
STXS
|
-538 M | $ 2.28 | -0.66 % | $ 184 M | USA |
 |
Retractable Technologies
RVP
|
26.7 M | $ 0.76 | -3.28 % | $ 22.8 M | USA |
 |
STAAR Surgical Company
STAA
|
-67.6 M | $ 23.07 | -0.62 % | $ 1.13 B | USA |
 |
Teleflex Incorporated
TFX
|
4.12 B | $ 121.85 | 0.18 % | $ 5.71 B | USA |
 |
Utah Medical Products
UTMD
|
138 M | $ 56.1 | -0.32 % | $ 204 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
-835 M | $ 11.41 | 0.13 % | $ 2.32 B | USA |
 |
West Pharmaceutical Services
WST
|
3.96 B | $ 275.08 | -0.65 % | $ 20.1 B | USA |